Digital Health at BIO 2022

As the leading platform for biopharma regulated digital health solutions, BrightInsight accelerates time to market and ensures compliance for our customers, including Sanofi, Novo Nordisk, Roche, CSL Behring, UCB and others.

Bio 2022 event photo

More about BrightInsight
Our proven, compliant platform accelerates your digital health journey

BrightInsight replaces the need for lengthy and complicated ‘build from scratch’ implementations and instead offers a pre-built and proven platform designed under a Quality Management System to support global security, privacy, and regulatory requirements.

 

Biopharma platform graphic gray circles

Our Customers

The world’s leading biopharma companies trust the BrightInsight Platform for their regulated digital health products including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD).

"We are excited to partner with BrightInsight, strengthening our commitment to addressing unmet needs in the rare disease space, and putting patients at the forefront of our innovations."

Colin Lake, VP, Head of Digital Business Transformation Neurology, UCB

Press Release
Customers ucb logo

"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."

Brian Johnson, Director, Digital Health, CSL Behring

Case Study
Customers CSL logo

"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."

Anders Dyhr Toft, Corporate Vice President, Commercial Innovation, Novo Nordisk

Learn More
Customers Novo logo